Halis Kaan Akturk Selected Research

Halis Kaan Akturk Research Topics

Disease

21	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2024 - 01/2018
6	Hypoglycemia (Reactive Hypoglycemia) 03/2024 - 01/2018
4	Weight Loss (Weight Reduction) 04/2024 - 03/2018
4	Type 2 Diabetes Mellitus (MODY) 03/2024 - 01/2018
4	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023 - 01/2018
3	Neoplasms (Cancer) 01/2020 - 03/2013
2	Body Weight (Weight, Body) 04/2024 - 02/2024
2	Obesity 04/2024 - 03/2013
2	Insulin Resistance 03/2024 - 01/2016
2	Hyperglycemia 02/2024 - 01/2022
2	Melanoma (Melanoma, Malignant) 12/2022 - 10/2018
2	Hypothyroidism 12/2022 - 10/2018
2	Weight Gain 10/2018 - 01/2018
1	Overweight 03/2024
1	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2023
1	Hypophysitis 12/2022
1	Hepatitis 12/2022
1	Pneumonia (Pneumonitis) 12/2022
1	Ketosis 11/2021
1	Melanosis (Freckles) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 10/2018
1	Autoimmune Hypothyroidism 10/2018
1	Hypertension (High Blood Pressure) 03/2018
1	Dyslipidemias (Dyslipidemia) 03/2018
1	Heart Diseases (Heart Disease) 03/2018
1	Fatigue 01/2018
1	Toxoplasmosis 03/2017
1	Multiple Sclerosis 03/2017
1	Hypoparathyroidism 01/2017
1	Hepatomegaly 01/2017
1	Optic Atrophy 01/2017
1	Osteomalacia 01/2017
1	Wolfram Syndrome (Syndrome, Wolfram) 01/2017
1	Hyperinsulinism (Hyperinsulinemia) 03/2013
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2013
1	Neuroblastoma 01/2012
1	Dementia (Dementias) 01/2012

Drug/Important Bio-Agent (IBA)

11	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2018
6	Insulin (Novolin)FDA Link 01/2023 - 03/2013
5	Immune Checkpoint InhibitorsIBA 01/2024 - 10/2018
3	tirzepatideIBA 04/2024 - 02/2024
2	Blood Glucose (Blood Sugar)IBA 03/2024 - 01/2024
2	Programmed Cell Death 1 ReceptorIBA 12/2022 - 10/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2022 - 01/2020
2	LigandsIBA 12/2022 - 10/2018
1	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2024
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2024
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2024
1	Hemoglobins (Hemoglobin)IBA 02/2024
1	CTLA-4 AntigenIBA 12/2022
1	HLA-DR Antigens (HLA-DR)IBA 12/2022
1	CarbohydratesIBA 01/2022
1	KetonesIBA 11/2021
1	AntibodiesIBA 01/2020
1	Insulin Aspart (NovoLog)FDA Link 10/2018
1	Monoclonal AntibodiesIBA 10/2018
1	SteroidsIBA 01/2018
1	Sodium-Glucose Transporter 1IBA 01/2018
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2018
1	dapagliflozinIBA 01/2018
1	Hormones (Hormone)IBA 01/2018
1	insulin degludecIBA 01/2018
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2017
1	Sulfadiazine (Sulphadiazine)FDA Link 03/2017
1	Pyrimethamine (Daraprim)FDA Link 03/2017
1	Growth Hormone (Somatotropin)IBA 01/2017
1	AngiotensinsIBA 01/2016
1	Chymosin (Rennin)IBA 01/2016
1	AldosteroneIBA 01/2016
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 03/2013
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 03/2013
1	Insulin Glargine (Lantus)FDA Link 03/2013
1	Human Immunodeficiency Virus rev Gene ProductsIBA 01/2012
1	platelet-derived growth factor C (PDGF-C)IBA 01/2012
1	Protein Isoforms (Isoforms)IBA 01/2012

Therapy/Procedure

8	Therapeutics 04/2024 - 01/2018
5	Glycemic Control 12/2023 - 01/2018
2	Immunotherapy 01/2020 - 10/2018
1	Ambulatory Care (Outpatient Care) 02/2024
1	Art Therapy 01/2020
1	Tattooing 01/2020
1	Renal Dialysis (Hemodialysis) 10/2018
1	Injections 10/2018